Small/Middle tier cities and County Lung Cancer Quality Improvement Project (QIP) study
Study identifier:D5161L00048
ClinicalTrials.gov identifier:NCT06494241
EudraCT identifier:N/A
CTIS identifier:N/A
Will Be Recruiting
Official Title
A multi-Center study to evaluate the guideline education of oncology departments in Small/Middle tier cities and County hospitals for diagnosis and treatment improvement in patients with Metastatic Non-small Cell Lung Cancer
Medical condition
Carcinoma, Non-Small-Cell Lung, Lung Diseases
Phase
Phase 4
Healthy volunteers
No
Study drug
-
Sex
All
Estimated Enrollment
1000
Study type
Observational
Age
18 Years - n/a
Date
Study Start Date: 28 Nov 2024
Estimated Primary Completion Date: 28 Nov 2027
Estimated Study Completion Date: 28 Nov 2027
Study design
Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Oct 2024 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Yilong WU
Guangdong Provincial People’s Hospital
